Anticoagulant heparan sulfate precursor structures in F9 embryonal carcinoma cells

J Biol Chem. 1999 Feb 26;274(9):5681-91. doi: 10.1074/jbc.274.9.5681.

Abstract

To understand the mechanisms that control anticoagulant heparan sulfate (HSact) biosynthesis, we previously showed that HSact production in the F9 system is determined by the abundance of 3-O-sulfotransferase-1 as well as the size of the HSact precursor pool. In this study, HSact precursor structures have been studied by characterizing [6-3H]GlcN metabolically labeled F9 HS tagged with 3-O-sulfates in vitro by 3'-phosphoadenosine 5'-phospho-35S and purified 3-O-sulfotransferase-1. This later in vitro labeling allows the regions of HS destined to become the antithrombin (AT)-binding sites to be tagged for subsequent structural studies. It was shown that six 3-O-sulfation sites exist per HSact precursor chain. At least five out of six 3-O-sulfate-tagged oligosaccharides in HSact precursors bind AT, whereas none of 3-O-sulfate-tagged oligosaccharides from HSinact precursors bind AT. When treated with low pH nitrous or heparitinase, 3-O-sulfate-tagged HSact and HSinact precursors exhibit clearly different structural features. 3-O-Sulfate-tagged HSact hexasaccharides were AT affinity purified and sequenced by chemical and enzymatic degradations. The 3-O-sulfate-tagged HSact hexasaccharides exhibited the following structures, DeltaUA-[6-3H]GlcNAc6S-GlcUA-[6-3H]GlcNS3(35)S+/-6S-++ +IdceA2S-[6-3H]Glc NS6S. The underlined 6- and 3-O-sulfates constitute the most critical groups for AT binding in view of the fact that the precursor hexasaccharides possess all the elements for AT binding except for the 3-O-sulfate moiety. The presence of five potential AT-binding precursor hexasaccharides in all HSact precursor chains demonstrates for the first time the processive assembly of specific sequence in HS. The difference in structures around potential 3-O-sulfate acceptor sites in HSact and HSinact precursors suggests that these precursors might be generated by different concerted assembly mechanisms in the same cell. This study permits us to understand better the nature of the HS biosynthetic pathway that leads to the generation of specific saccharide sequences.

Publication types

  • Research Support, U.S. Gov't, Non-P.H.S.
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Anticoagulants / chemistry
  • Anticoagulants / metabolism*
  • Antithrombins / metabolism
  • Binding Sites
  • Carbohydrate Conformation
  • Carbohydrate Sequence
  • Carcinoma, Embryonal / metabolism
  • Carcinoma, Embryonal / pathology
  • Chromatography, Gel
  • Chromatography, High Pressure Liquid
  • Heparitin Sulfate / chemistry
  • Heparitin Sulfate / metabolism*
  • Molecular Sequence Data
  • Oligosaccharides / chemistry
  • Sulfates / chemistry
  • Tumor Cells, Cultured

Substances

  • Anticoagulants
  • Antithrombins
  • Oligosaccharides
  • Sulfates
  • Heparitin Sulfate